NYMOX PHARMACEUTICAL CORP Insider Trading for July 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NYMOX PHARMACEUTICAL CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NYMOX PHARMACEUTICAL CORP for July 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.62 | 2,500 | 9,050 | 2,900,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.63 | 2,500 | 9,075 | 2,897,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.70 | 2,500 | 9,250 | 2,895,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.80 | 2,500 | 9,500 | 2,892,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.89 | 2,500 | 9,725 | 2,890,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.98 | 2,500 | 9,950 | 2,887,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.03 | 2,500 | 10,075 | 2,885,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.10 | 2,500 | 10,250 | 2,882,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 29 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 4.02 | 2,500 | 10,050 | 2,880,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.41 | 2,500 | 8,525 | 2,877,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.35 | 2,500 | 8,375 | 2,875,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.27 | 2,500 | 8,175 | 2,872,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 2,500 | 8,225 | 2,870,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.41 | 2,500 | 8,525 | 2,877,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.35 | 2,500 | 8,375 | 2,875,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.27 | 2,500 | 8,175 | 2,872,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 22 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.29 | 2,500 | 8,225 | 2,870,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.20 | 2,500 | 8,000 | 2,867,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.17 | 4,089 | 12,962 | 2,865,050 | 2.9 M to 2.9 M (+0.14 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.21 | 911 | 2,924 | 2,860,961 | 2.9 M to 2.9 M (+0.03 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.20 | 2,500 | 8,000 | 2,860,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.33 | 2,500 | 8,325 | 2,857,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.33 | 2,500 | 8,325 | 2,855,050 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.41 | 2,500 | 8,525 | 2,852,550 | 2.9 M to 2.9 M (+0.09 %) |
| Jul 07 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.43 | 2,500 | 8,575 | 2,850,050 | 2.8 M to 2.9 M (+0.09 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.36 | 1,500 | 5,040 | 2,847,550 | 2.8 M to 2.8 M (+0.05 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.45 | 3,000 | 10,350 | 2,846,050 | 2.8 M to 2.8 M (+0.11 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.71 | 2,500 | 9,275 | 2,843,050 | 2.8 M to 2.8 M (+0.09 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.74 | 3,500 | 13,090 | 2,840,550 | 2.8 M to 2.8 M (+0.12 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.40 | 2,500 | 8,500 | 2,837,050 | 2.8 M to 2.8 M (+0.09 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.45 | 1,500 | 5,175 | 2,834,550 | 2.8 M to 2.8 M (+0.05 %) |
| Jul 01 2016 | NYMX | NYMOX PHARMACEUTIC ... | Robinson James George | Director | Buy | P | 3.42 | 3,000 | 10,260 | 2,833,050 | 2.8 M to 2.8 M (+0.11 %) |